Case StudyClinical JUL 01, 2023
A late-stage biotechnology company developing a next-generation vaccine against COVID-19 was set to conduct a large Phase III trial. The trial design was aligned with other Phase III trials conducted under the auspices of Operation Warp Speed. Citeline Connect was selected to support the trial’s 30,000-participant goal.
Your campaign has been very successful for us!
Discover relevant products
Related Resources